{"id":432888,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2018-01-04] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:06:48.321000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-19.html?wbdisable=true","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions Janurary 4, 2018 Our reference number: 17-114235-356 The purpose of this Notice of Amendment is to notify about the additions of durvalumab, glycopyrrolate, letermovir, migalastat, netupitant/palonosetron hydrochloride to…","rawSnapshotUrl":"/api/snapshots/raw/432888","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090648/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-19.html?wbdisable=true#ha_snapshot=432888","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}